PTCT News and Press, PTC Therapeutics Inc. From 02/05/26

PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 PR Newswire WARREN, N.J. , Feb. 5, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to...

2026-01-12 14:56:00 ET PTC Therapeutics, Inc. (PTCT) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 12:00 PM EST... Read the full article on Seeking Alpha For further details see: PTC Therapeutics, Inc. (PTCT) Presents at 44th Annual J.P. Morgan Healthcare Co...

2026-01-12 11:09:21 ET More on PTC Therapeutics PTC Therapeutics downgraded at RBC as Sephience sales priced in Sandisk to join S&P 500; UPWK, FIBK, HBI to be part of S&P SmallCap 600 Read the full article on Seeking Alpha For further details see: ...

PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference PR Newswire – Strong Sephience™ (sepiapterin) launch continues with unaudited Q4 global revenue of $92.5M – – Unaudited 2025 total product and royalty revenue of approxima...

2025-12-30 08:57:41 ET Since my October article , Biogen Inc. ( BIIB ) stock has risen 18.4%, outperforming the S&P 500 [2.9% return] ( SPY ), as well as two "bellwethers" for the biotech investors, the iShares Biotechnology ETF [14%] ( IBB ) and VanEck Biotech ETF [...

2025-12-29 17:13:13 ET More on Royalty Pharma Royalty Pharma plc (RPRX) Presents at Evercore 8th Annual Healthcare Conference Transcript Royalty Pharma plc (RPRX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript Royalty Pharma: Guidance Raised Aga...

PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan PR Newswire – Indication includes all ages and the full spectrum of disease severity – – First Japan...

2025-12-19 11:57:12 ET More on iShares Russell 2000 ETF If It Walks Like A Duck... 2026 Market Outlook: The Year Of Real Assets As AI Hype Reaches Peak Why I Think XLY And XLC Stand Out Over Tech In 2026 Stocks will continue to broaden beyond the mega-caps in...

PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire WARREN, N.J. , Dec. 18, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that CEO Matthew B. Klein , M.D., will present at the 44 th Annual J.P. Morgan Hea...

PTC Therapeutics Announces Health Canada Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) Canada NewsWire - Broad label includes all age groups and full range of PKU subtypes - TORONTO , Dec. 10, 2025 /CN...